ORCH Insider Trading Activity and SEC Form 4 Filings
ORCH insider trading summary
No open-market insider purchases or sales of Orchid Cellmark Inc (ORCH) have been reported on SEC Form 4 in the past 12 months.
Latest ORCH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 15, 2011 | Laboratory Corp of America Holdings | 10% Owner | Buy | $145K (51,937 @ $2.80) |
| Dec 15, 2011 | Laboratory Corp of America Holdings | 10% Owner | Buy | $23.2M (8,273,065 @ $2.80) |
| Dec 14, 2011 | Laboratory Corp of America Holdings | 10% Owner | Buy | $378K (134,943 @ $2.80) |
| Dec 13, 2011 | Laboratory Corp of America Holdings | 10% Owner | Buy | $85K (30,304 @ $2.80) |
| Aug 26, 2010 | Thomas A Bologna | President and CEO | Buy | $1K (1,000 @ $1.42) |
| Aug 25, 2010 | Thomas A Bologna | President and CEO | Buy | $1K (1,000 @ $1.42) |
| Aug 23, 2010 | Thomas A Bologna | President and CEO | Buy | $1K (1,000 @ $1.48) |
| Aug 19, 2010 | Thomas A Bologna | President and CEO | Buy | $2K (1,626 @ $1.50) |
| Dec 23, 2009 | Gabe Hoffman | 10% Owner | Sell | $1.1M (724,853 @ $1.57) |
| Dec 23, 2009 | Accipiter Life Sciences Fund LP | Insider | Sell | $1.1M (724,853 @ $1.57) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.